Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 Cells/mm3: Findings from the Strategic Timing of AntiRetroviral Therapy (START) Trial

INSIGHT START Study Group

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 Cells/mm3: Findings from the Strategic Timing of AntiRetroviral Therapy (START) Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences